Sana Biotechnology
SANA
SANA
105 hedge funds and large institutions have $1.73B invested in Sana Biotechnology in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
22% less call options, than puts
Call options by funds: $398K | Put options by funds: $511K
30% less capital invested
Capital invested by funds: $2.48B → $1.73B (-$751M)
Holders
105
Holding in Top 10
5
Calls
$398K
Puts
$511K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$13.5M | |
| 3 | +$6.05M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.71M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$10.8M | |
| 3 | -$9.07M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.83M |
| 5 |
Morgan Stanley
New York
|
-$2.6M |